LABORIE MEDICAL TECHNOLOGIES CORP.
2 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (2)
- Inspections (2)
Devices registered here (1)
- UroflowmeterProduct code EXY (opens in a new tab) · Class II · Gastroenterology, Urology · 21 CFR 876.1800
Recalls & enforcement
- Class IIOngoing2026-05-21Under extended clinical use conditions (e.g., long duration studies), moisture generated within the pneumatic circuit may accumulate inside the system's internal tubing or at the hydrophobic filter and waterproof pressure sensors. Accumulated moisture may affect airflow or pressu…
- Class IITerminated2019-07-17Power supply unit (PS-SBL) not correctly labeled, and insulation material used at the low voltage DC end does not meet all applicable flammability rating requirements. may lead to a potential fire hazard
FDA inspections (2)
- NAI2020-02-26No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices
- NAI2016-02-22No Action Indicated · Compliance: Devices
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “LABORIE MEDICAL TECHNOLOGIES CORP. (FEI 3017448360) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3017448360-laborie-medical-technologies-corp/
Alerts for LABORIE MEDICAL TECHNOLOGIES CORP.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.